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Mitochondria are typically essential for the viability of eukaryotic cells, and utilize oxygen and
nutrients (e.g. glucose) to perform key metabolic functions that maintain energetic home-
ostasis and support proliferation. Here we provide a comprehensive functional annotation of
mitochondrial genes that are essential for the viability of a large panel (625) of tumour cell
lines. We perform genome-wide CRISPR/Cas9 deletion screening in normoxia-glucose,
hypoxia-glucose and normoxia-galactose conditions, and identify both unique and over-
lapping genes whose loss influences tumour cell viability under these different metabolic
conditions. We discover that loss of certain oxidative phosphorylation (OXPHOS) genes (e.g.
SDHC) improves tumour cell growth in hypoxia-glucose, but reduces growth in normoxia,
indicating a metabolic switch in OXPHOS gene function. Moreover, compared to normoxia-
glucose, loss of genes involved in energy-consuming processes that are energetically
demanding, such as translation and actin polymerization, improve cell viability under both
hypoxia-glucose and normoxia-galactose. Collectively, our study defines mitochondrial gene
essentiality in tumour cells, highlighting that essentiality is dependent on the metabolic
environment, and identifies routes for regulating tumour cell viability in hypoxia.
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A ltered mitochondrial metabolism and function contributeto several pathologies, including cancer. Tumour micro-environmental conditions, such as hypoxia, and changes
in nutrient availability can profoundly impact mitochondrial
activity, providing metabolic adaptive responses that enable
tumour cell survival and promote metastasis1. Mitochondrial
function is essential for supporting tumour cell proliferation,
through the generation of ATP via OXPHOS, and the synthesis of
precursors for biomass accumulation, such as amino acids, lipids
and nucleotides. Agents that target OXPHOS inhibit cell growth
across a broad range of tumour cell types2,3, while inactivating
mutations in mitochondrial genes have also been shown to
influence tumour cell proliferation, both positively and negatively,
depending on the gene and cell context4,5.
Mitochondrial ATP synthesis and many other mitochondrial
metabolic reactions rely on the intracellular availability of mole-
cular oxygen, and it has been estimated that mitochondria
account for >90% of cellular oxygen consumption6. Thus, mito-
chondria are key determinants of cell and tissue oxygenation
levels and have been shown to regulate the development of
intracellular hypoxia7,8. Hypoxia is a characteristic feature of the
tumour microenvironment, contributing to disease progression,
and is associated with treatment resistance9 and poor prognosis
in patients with solid malignancies10. Hypoxia also constitutes
mitochondrial stress, as a reduction in oxygen availability limits
the activity of the respiratory chain11. Metazoan cells have
evolved several pathways that sense and respond to changes in
oxygen levels, such as the hypoxia-inducible factor (HIF)
pathway1,12, which allows them to adapt in order to maintain
cellular homoeostasis and survive1. Indeed, a reduction in oxygen
availability has wide-ranging effects on multiple cellular func-
tions, and our understanding of the genes and pathways that
contribute to hypoxic adaptation continues to grow but is
incomplete.
The development of CRISPR/Cas9 gene-editing technology
has facilitated the investigation of cellular responses to stimuli
at a genome-wide scale13–15. Here, we performed genome-wide
CRISPR/Cas9 deletion screening under different environmental
conditions (normoxia-glucose, hypoxia-glucose, and normoxia-
galactose) to interrogate the dependency of tumour cells on
nuclear-encoded mitochondrial genes (referred to as mito-
chondrial genes) and non-mitochondrial genes for their survi-
val when oxygen or glucose is abundant or limited. We provide,
what we believe to be, the first comprehensive functional
annotation of the nuclear-encoded mitochondrial genome, and
classify functional modules of genes that are commonly
essential across different tumour cell types. We show that
proportionally, twice as many mitochondrial genes are com-
mon essential genes when compared to the genome as a
whole. Under hypoxia, loss of mitochondrial genes, including
OXPHOS genes such as succinate dehydrogenase subunit C
(SDHC), improves the growth of U2OS cells, as well as HeLa
and MCF7 cells, and downregulated expression of OXPHOS
proteins is an intrinsic response of tumour cells to hypoxia.
Conversely, switching the carbon fuel from glucose to galactose
to drive mitochondrial respiration significantly increases the
essentiality of certain mitochondrial genes for the survival and
proliferation of tumour cells. In addition, we show that loss of
genes involved in energy-consuming processes that are energe-
tically demanding, such as translation and cytoskeleton
arrangement, improve the viability of tumour cells under either
hypoxia or galactose. Our study provides a comprehensive
survey of mitochondrial gene essentiality in tumour cells,
which shows that gene essentiality depends on the metabolic
context, and highlights routes for tumour cell viability in
hypoxia.
Results
The essentiality of mitochondrial genes in tumour cells.
Mitochondria play an essential role in maintaining bioenergetic
and biosynthetic homoeostasis to support cell division. While
mitochondria contain a well-characterised genome encoding 13
proteins essential for mitochondrial function, there are hundreds
of nuclear genes that also encode mitochondrial proteins16, but
their role in tumour cell survival is less well understood. In order
to better understand the essentiality of mitochondrial genes for the
survival of tumour cells, first, we analysed the gene essentiality
scores from the Broad Institute’s Achilles Project17,18, which
provides data on genome-wide CRISPR loss-of-function screens,
covering 18,333 genes (excluding the 13 protein-coding genes
from the mitochondrial genome) in 625 genomically characterised
cancer cell lines (as of 19Q3 data release)19. In this dataset,
common essential genes are defined as a gene that, in a large, pan-
cancer screen, ranks in the top X most depleting genes in at least
90% of cell lines. X is chosen empirically using the minimum of
the distribution of gene ranks in their 90th percentile least
depleting lines. We sorted the essentiality data for mitochondrial
genes using the MitoCarta 2.0 database of genes encoding
mitochondrial-localised proteins20, totalling 1137 of the 1158
MitoCarta 2.0 genes (Fig. 1a, Supplementary Data 1), which
excludes 22 genes not targeted in the Achilles Project sgRNA
library. To gain a comprehensive understanding of the mito-
chondrial genes and pathways that are most essential for tumour
cell survival, we next manually functionally annotated each gene
according to published data, which we believe to be the first such
full annotation of the mitochondrial proteome (Fig. 1a, Supple-
mentary Data 1). We were able to assign a functional annotation
for 91% (1041) of all MitoCarta 2.0 genes (Fig. 1a). Interestingly, a
greater proportion of mitochondrial genes (23.2%) were common
essential genes, as compared to the proportion of common
essential genes in the genome as a whole (11.5%, Fig. 1b, Sup-
plementary Data 1), in line with other studies of this kind14. This
analysis identified that the largest groups of common essential
mitochondrial genes are involved in respiration, mitochondrial
gene expression and mitochondrial functions that are well char-
acterised as being required for the survival and proliferation of
tumour cells including mitochondrial import and sorting (e.g.
CHCHD43,21–23) (Fig. 1c). Our functional annotation also allowed
us to identify a number of functional modules of genes that
represent common essential pathways, such as phosphate meta-
bolism (PPA2, SLC25A3), and carbonic acid metabolism (CA5A)
(Fig. 1c). Thus, through our analysis, we have provided a com-
prehensive overview of the essentiality of mitochondrial genes in
tumour cells, cultured under standard normoxic conditions.
Genome-wide CRISPR deletion screen under different meta-
bolic conditions. Next, we performed a genome-wide CRISPR/
Cas9 deletion screen under three different metabolic conditions in
parallel, to identify mitochondrial and non-mitochondrial genes
and pathways that determine tumour cell fitness under tumour
relevant conditions (Supplementary Fig. 1a). To model conditions
of reduced oxygen and glucose availability, commonly found in
solid tumours, we compared gene essentiality in (i) glucose media
and normoxia (normoxia-glucose), (ii) glucose media and hypoxia
(1% O2) (hypoxia-glucose) and (iii) galactose media and normoxia
(normoxia-galactose). Notably, two previous independent studies
from the same group have described genome-wide CRISPR/
Cas9 screens—the first in galactose which assessed dying cells14,
and the second in hypoxia which assessed viable cells15. Both stu-
dies used a non-adherent immortalised chronic myelogenous leu-
kaemic (CML) cell line, K56214,15. Thus here, we perform the first
genome-wide CRISPR/Cas9 deletion screen comparing these three
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Fig. 1 The essentiality of mitochondrial genes in tumour cells. a Schematic diagram shows our analysis pathway for using the Achilles cancer dependency
map (DepMap) gene essentiality data. b Pie charts show the percentage of common essential genes (shown in yellow) among mitochondrially expressed
genes (left chart), and among all genes screened (right chart) in (a). Other (non-common essential) genes (shown in blue). c List of common essential
mitochondrially expressed genes identified in (a), grouped by functional annotation. (*) indicates genes with multiple functions.
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different metabolic conditions in parallel, using the same screening
methodology, and in triplicate. For our study, we selected human
osteosarcoma U2OS-HRE-luc cells (referred to as U2OS) originally
described by us in a high throughput primary screening context24.
U2OS cell responses to hypoxia have been well characterised by our
group previously8,21,23,24, and these cells carry no known mutations
in the canonical hypoxia-responsive HIF pathway, unlike the CML
K562 cell line used in the previous genome-wide CRISPR
studies14,15. Moreover, the reduction of U2OS cell growth in
hypoxia (1% O2) compared to normoxia, is relatively small (Sup-
plementary Fig. 1b), and thus they represent a relevant model for
hypoxia-adapted tumours. U2OS cells stably expressing the Cas9
enzyme (U2OS-Cas9) were generated as described (see Materials
and Methods), and confirmation of active Cas9 expression was
carried out using a dual fluorescent reporter system. Following
lentiviral transduction of a genome-wide CRISPR/Cas9 library and
puromycin selection (14–15 days), U2OS-Cas9 cells were incubated
for 5 days under each condition, harvested and then sequenced for
sgRNA abundance (Supplementary Fig. 1a). This time frame of
prolonged hypoxia exposure promotes significant changes in
hypoxia gene expression (Supplementary Fig. 1c) and results in
metabolically adaptive cellular responses. The sequencing reads
were analysed using the MAGeCK (version 0.5.6) platform to
identify significantly enriched or depleted genes between respective
conditions25 (Supplementary Data 2–4).
In our initial analysis we verified the success of the
experimental design by comparing the relative abundance of
sgRNAs in U2OS-Cas9 cells transduced with the sgRNA library
compared to plasmid only for each replicate under each condition
(Supplementary Fig. 2a–f). Analysis of the most significantly
depleted genes (false-discovery rate (FDR) <30%) in all three
replicates (Supplementary Data 2) identified overrepresentation
of genes involved in essential cellular processes such as mRNA
processing, cell cycle progression, and OXPHOS (Supplementary
Fig. 2g). There was direct corroboration between the over-
represented genes in our depleted gene list, and the common
essential genes identified by the Achilles project (compare
Supplementary Fig. 2g, h), giving us confidence in our screening
strategy. Conversely, the most significantly enriched sgRNAs
targeted known tumour suppressors and pro-apoptotic genes,
such as NF2, TP53 and NOXA1 (Supplementary Fig. 3).
Hypoxia promotes the loss of mitochondrial genes and genes
involved in energy-consuming processes. Next, we compared
sgRNA abundance in U2OS-Cas9 cells cultured for 5 days in
hypoxia-glucose compared to cells cultured in normoxia-glucose
(Fig. 2a). First, we verified the success of the sgRNA transduction
in hypoxia by comparing the abundance of individual sgRNAs in
cells transduced with sgRNA library to those transduced with
plasmid only (Supplementary Fig. 2b, e). Of the most significantly
depleted genes (FDR < 30%) across all three replicates (Supple-
mentary Data 3), our analysis identified overrepresentation of
genes from pathways regulating essential cellular functions e.g.
cell cycle, and RNA processing (Supplementary Fig. 4a), similar
to cells cultured in normoxia (Supplementary Fig. 2g). Compared
to normoxia, we identified 179 genes with significantly enriched
sgRNAs in hypoxia, and 18 genes with significantly depleted
sgRNAs (FDR < 30%) (Fig. 2b). This latter observation was not
surprising, as we have found that U2OS cells tolerated exposure
to prolonged hypoxia, as indicated by the small effect of hypoxia
on the growth of U2OS cells under these conditions (Supple-
mentary Fig. 1b). Interestingly, 18.4% (33/179) of the sgRNAs
significantly enriched in hypoxia targeted mitochondrial genes
(Fig. 2c), including several subunits of the respiratory complexes,
and genes that regulate the expression of genes from the
mitochondrial genome (Fig. 2d, Supplementary Table 1). How-
ever, only 5.5% (1/18) of the sgRNAs significantly depleted in
hypoxia targeted mitochondrial genes (Fig. 2c). Moreover, at least
9 of the 33 mitochondrial genes that had significantly enriched
sgRNAs in hypoxia were significantly depleted (FDR < 30%) in
U2OS-Cas9 cells cultured in normoxia (Fig. 2d, Supplementary
Table 1), collectively demonstrating that the essentiality of
mitochondrial genes is context-specific, and influenced by
environmental oxygen conditions. Notably, culturing U2OS or
HCT116 cells in hypoxia for 5 days led to a reduction in the
expression of a panel of subunits of respiratory complexes (C)
I–IV involved in cell fitness21 concurrent with an increase in the
expression of HIF targets such as BNIP3 (Fig. 2e, Supplementary
Fig. 4b). Our data support the idea that suppression of mito-
chondrial gene expression is an intrinsic response to prolonged
exposure to hypoxia, conferring a fitness advantage to cells. The
downregulation of mitochondrial function under hypoxia has
previously been reported26. Also, downregulation of respiration
in renal carcinoma cells has been attributed to the action of the
HIF pathway on the activity of MYC and PGC1α, which regulate
mitochondrial biogenesis27,28. Interestingly, we found no con-
comitant reduction in mtDNA copy number after 5 days of
hypoxic culture in U2OS, or HCT116 cells (Supplementary
Fig. 5a). Indeed, much research into the cellular response to
hypoxia has focused on the HIF pathway and its regulation
through hydroxylation by oxygen-dependent dioxygenases.
However, none of the HIF pathway genes, including key reg-
ulators (e.g. EGLN1-3 and VHL) had significantly altered sgRNA
abundances under hypoxia compared with normoxia (Supple-
mentary Fig. 5b), suggesting that the viability of U2OS cells under
these culture conditions does not appear to be influenced by loss
of components of the HIF pathway. Importantly, these findings
corroborate a recent study that also did not identify HIF pathway
genes as being essential for the growth of K562 cells15 which carry
a mutation in the EPAS1 (HIF-2α) gene18 that is predicted to lead
to a truncated protein product lacking the C-terminal oxygen-
dependent domain.
Besides identifying genes involved in OXPHOS, overrepresenta-
tion analysis of the data from our CRISPR/Cas9 deletion screen in
hypoxia-glucose compared to normoxia-glucose also identified
significant (FDR < 30%) enrichment of sgRNAs targeting non-
mitochondrial genes involved in mRNA processing and regulation
of the actin cytoskeleton (Fig. 2f). Further analysis using protein
interaction databases identified three major interacting nodes of
genes (Supplementary Fig. 5c): a cluster of mitochondrial genes, a
cluster of seven genes involved in mRNA processing (Fig. 2g), and
a cluster of genes involved in cytoskeleton arrangement, including
actin polymerisation (ARPC2, FNBP1, CDC42) and centromere
attachment to microtubules (INCENP, KIF18A) (Fig. 2h). Both
transcription/translation and cytoskeleton arrangement are
energy-consuming processes that are energetically demanding29,30,
and as hypoxia constitutes an energetic stress, it is likely that loss of
these genes improves cellular energy homoeostasis and promotes
fitness when oxygen is limiting. Downregulation of transcription
and translation is already a well-characterised cellular response to
hypoxia, signalled by a reduction in the ATP/ADP ratio31,32, but
precisely how the genes identified here are involved in the cellular
response to hypoxia has yet to be described.
Loss of SDHC improves tumour cell growth in hypoxia. The
most significantly enriched sgRNAs in hypoxia-glucose compared
with normoxia-glucose treated cells targeted SDHC, a subunit of
respiratory complex II, and an enzyme of the tricarboxylic acid
(TCA) cycle (Fig. 3a). Therefore, we decided to further validate
SDHC to demonstrate the influence of mitochondrial gene
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expression on tumour cell growth in hypoxia. Silencing of SDHC
(Supplementary Fig. 6a) improved the growth of U2OS cells in
hypoxia (Fig. 3b), demonstrating that the suppression of mito-
chondrial function under hypoxia represents a survival response.
We confirmed these findings in two other tumour cell lines of
different aetiologies, namely MCF7 (breast adenocarcinoma) and
HeLa (cervical carcinoma) cells (Supplementary Fig. 6b).
Interestingly, in the colon carcinoma cell line HCT116 where
there is a significant reduction in growth in hypoxia, knockdown
of SDHC did not improve proliferation in hypoxia, and instead
significantly reduced cell growth in hypoxia (Supplementary
Fig. 6b). In addition, we found that knockdown of SDHC in HeLa
and HCT116 cells led to a significant reduction in cell growth in
normoxia with a trend in reduction in cell growth in MCF7 cells
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(Supplementary Fig. 6b). Notably, we did not observe a reduction
in U2OS cell growth in normoxia upon SDHC knockdown
although SDHC had been identified as an essential gene from the
Achilles project (Fig. 1c), and was depleted in our CRISPR screen
(normoxia-glucose, Supplementary Data 2). Collectively these
data indicate that U2OS cells tolerate knockdown but not
knockout of SDHC in normoxia-glucose. We found that in U2OS
cells, SDHC expression was significantly reduced after 5 days of
hypoxic culture at both the protein level (Fig. 3c, d) and transcript
level (Fig. 3e), in line with the reduced expression of other sub-
units of respiratory chain complexes (Fig. 2e). Thus, down-
regulation of SDHC (and other respiratory complex subunits)
appears to be an intrinsic response to hypoxia, which provides a
proliferative advantage to cells. Indeed, we found that replacing
glucose with galactose—which forces the cells to utilise OXPHOS
for the generation of ATP and thus increases basal oxygen con-
sumption rate (OCR) (Supplementary Fig. 6c, d) and reduces
lactate production (Supplementary Fig. 6e)—abrogated the pro-
tective effect of SDHC silencing in hypoxia (Fig. 3f). Furthermore,
in the presence of galactose, SDHC silencing significantly reduced
the growth of cells, when compared to control siRNA treated
cells, in both normoxia and hypoxia (Fig. 3f), and interestingly,
this reduction in cell growth was more significant in hypoxia
compared to normoxia (Fig. 3f). Taken together, our data
demonstrate the contextual nature of mitochondrial gene essen-
tiality and suggest that genetic loss of mitochondrial function
improves cell fitness in hypoxia when there is glucose to support
non-oxidative ATP production.
Galactose increases mitochondrial gene essentiality. Since
hypoxia suppressed mitochondrial respiratory complex subunit
protein expression (Fig. 2e), and led to a reduction in mito-
chondrial gene essentiality (Fig. 2d), next, we investigated whe-
ther stimulating increased mitochondrial activity reversed these
changes. Therefore, we repeated the genome-wide CRISPR/Cas9
deletion screen, with U2OS-Cas9 cells cultured in normoxia, in
either glucose or (glucose-free) galactose media for 5 days prior to
sgRNA sequencing and analysis (Supplementary Fig. 1a, Fig. 4a,
Supplementary Data 4). Galactose forces cells to rely on OXPHOS
to maintain ATP homoeostasis, since metabolism of galactose to
pyruvate leads to no net ATP generation, unlike the metabolism
of glucose. When comparing sgRNA abundance in U2OS-Cas9
cells incubated in normoxia-galactose versus normoxia-glucose
(Fig. 4a), 32% (59/187) of the most significantly (FDR < 30%)
depleted sgRNAs targeted mitochondrial genes (Fig. 4b),
including 29 subunits and assembly factors of respiratory chain
complexes, as well as genes involved in the TCA cycle, and
diverse other metabolic processes (Fig. 4c). Importantly, few (6/
188) of these genes were significantly depleted in U2OS-Cas9 cells
cultured in normoxia-glucose, when comparing cells transduced
with sgRNA library to cells transduced with plasmid control
(Fig. 4c, highlighted in brown). Furthermore, of the significantly
enriched sgRNAs in cells cultured in normoxia-galactose com-
pared to normoxia-glucose, 8% (13/169) targeted mitochondrial
genes (Fig. 4b). Collectively, this demonstrates that replacing
glucose with galactose increases the essentiality of mitochondrial
genes from different pathways in tumour cells, highlighting their
increased reliance on mitochondrial function for fitness under
these conditions. Indeed, U2OS cells were more sensitive to the
complex I inhibitor rotenone when cultured in normoxia-
galactose compared to normoxia-glucose (Fig. 4d), further sup-
porting the increased essentiality of mitochondrial function in the
absence of glucose. Interaction analysis of the genes with the most
significantly depleted sgRNAs identified OXPHOS genes as the
largest interacting node (Supplementary Fig. 7a). In addition, this
analysis identified a related node comprising three genes involved
in ROS detoxification (GPX3, SELO, TXNRD2) (Supplementary
Fig. 7a), which likely become more essential since mitochondrial
respiration and ROS production are concomitantly increased in
the presence of galactose.
Interestingly, when comparing significantly enriched sgRNAs
in hypoxia-glucose with those significantly enriched sgRNAs
identified in normoxia-galactose, we identified several over-
lapping genes. Indeed, as in hypoxia (Fig. 2f), we found that many
of the most significantly enriched sgRNAs in galactose (compared
to normoxia-glucose) targeted genes involved in mRNA proces-
sing and translation (Fig. 4e). Interaction analysis identified a
node of genes including ribosomal subunits (RPL6, RPS18) and
elongation factors (EEF2, EIF3I) involved in RNA processing
(Fig. 4f). Furthermore, there was also significant enrichment of
sgRNAs targeting genes involved in cytoskeleton arrangement
(Supplementary Fig. 7b), including genes involved in centromere
attachment to the cytoskeleton (INCENP, KIF18A), and actin
polymerisation (ACTR3, ARPC4) (Supplementary Fig. 7b). All
four genes were also identified as significantly depleted sgRNAs in
normoxia-glucose (Supplementary Data 2), and are classed as
common essential genes by the Achilles project17,18. As both
galactose and hypoxia constitute energetic stress, loss of genes
involved in these energy-consuming processes likely helps cells
maintain energetic homoeostasis under both conditions. Over-
representation analysis of the genes with significantly enriched
sgRNAs also identified enrichment of genes involved in glycolysis
and gluconeogenesis (Fig. 4e). We identified eight genes are
involved in hexose carbon metabolism (Fig. 4g, Supplementary
Fig. 7c), including six genes involved in glycolysis (GPI, LDHD,
PGAM, PGK1, PKM, TPI1) and two involved in the pentose
phosphate shunt (G6PD, PGD) (Fig. 4g, Supplementary Fig. 7d).
Indeed, PGAM and GPI were the two genes whose sgRNAs were
most significantly enriched in normoxia-galactose compared to
normoxia-glucose (Fig. 4g). Metabolism of galactose for use in
OXPHOS first involves its conversion to glucose-6-phosphate
(G6P), followed by metabolism via the canonical glycolysis
Fig. 2 Hypoxia promotes loss of mitochondrial genes and genes involved in energy-consuming processes. a Schematic diagram shows which datasets
were compared in our analysis (hypoxia-glucose vs. normoxia-glucose). Sequencing reads from triplicate incubations were analysed by the MAGeCK
analysis platform, and relative sgRNA abundances were calculated between experimental conditions. b Charts show FDR-corrected significance values of
all sequenced genes, with significantly enriched (blue circles) or depleted (brown circles) sgRNAs in cells cultured in hypoxia-glucose compared to
normoxia-glucose. n= 3. p < 0.05, FDR < 30%. c Pie charts show number of mitochondrial genes among the genes identified with significantly enriched or
depleted sgRNAs from cells in (a). d Panel shows 31 selected mitochondrial genes with significantly enriched sgRNAs from (b). Genes significantly
depleted in normoxia-glucose (plasmid vs. library) are highlighted in brown. e Western blots show expression of NDUFB10, SDHA, UQCRC2, COXIV, and
BNIP3 in U2OS and HCT116 cells incubated for 5 days in normoxia (Nor) or hypoxia (Hyp, 1% O2). β-Actin used as a loading control. f Chart shows
overrepresentation analysis of all genes with significantly enriched sgRNAs in hypoxia (hypoxia-glucose vs. normoxia-glucose). Gene sets involving
translation (mRNA splicing and processing of pre-mRNA), and regulation of actin cytoskeleton are highlighted (*). g, h Schematic diagram shows clusters
of interacting genes with significantly enriched sgRNAs in hypoxia (hypoxia-glucose vs. normoxia-glucose) involved in mRNA processing (g), and
cytoskeleton arrangement (h).
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Fig. 3 Loss of SDHC improves tumour cell growth in hypoxia. a Chart shows all genes with significantly enriched sgRNAs (robust rank aggregation (RRA)
score, positive) in hypoxia-glucose at different FDR thresholds. b Chart shows relative growth of U2OS cells cultured for 5 days in normoxia or hypoxia (1%
O2) treated with non-targeting control siRNA (siCtrl) or siRNA targeting SDHC (siSDHC). n= 3. Mean ± S.D.; n.s. not significant; ***p < 0.001. c Western
blots show expression of SDHC, and BNIP3 in U2OS cells incubated for 5d in normoxia (Nor) or hypoxia (Hyp, 1% O2). β-Actin used as a loading control.
d Chart shows the relative density of SDHC bands from samples in (c). n= 3; mean ± S.D.; **p < 0.01. e Charts show expression of SDHC and EGLN3 from
U2OS cells incubated for 5d in normoxia or hypoxia (1% O2). n= 3; mean ± S.D.; **p < 0.01. f Charts show relative growth of U2OS cells incubated for 5d in
normoxia or hypoxia (1% O2), in the presence of 25mM galactose, treated with non-targeting control siRNA (siCtrl) or siRNA targeting SDHC (siSDHC).
n= 3; mean ± S.D.; n.s. not significant; *p < 0.05; **p < 0.01.
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pathway (Supplementary Fig. 7d). A reduction in the diversion of
galactose-derived G6P to the pentose phosphate pathway may
help maximise ATP production through OXPHOS to support
survival/proliferation, as well as loss of LDHD to reduce pyruvate
fermentation to lactate. However, it is unclear why the loss of
genes involved in glycolysis would also be beneficial, though it
may be that this conserves the intracellular pool of glucose for
other processes, or promotes the metabolism of alternative carbon
sources, such as glutamine, to support OXPHOS.
Discussion
Mitochondria are involved in regulating eukaryotic cell survival
and growth, through their essential roles in controlling
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bioenergetic and biosynthetic homoeostasis. Here, we show the
essentiality of (nuclear-encoded) mitochondrial genes is context-
specific, and that tumour-relevant microenvironmental condi-
tions such as hypoxia or changes in nutrients (e.g. glucose), alters
the dependency of tumour cells on mitochondrial genes for their
survival and growth. Our findings corroborate those described in
two independent studies in which hypoxia15 and galactose
media14 were used in genome-wide CRISPR/Cas9 screens to
interrogate gene essentiality, but which used different meth-
odologies from our study and different cells14,15. Several of the
mitochondrial genes whose loss improved U2OS cell fitness in
hypoxia have been classed as common essential genes by the
Achilles Project and were significantly depleted in normoxia in
our CRISPR/Cas9 deletion screen. The finding that mitochondrial
(and non-mitochondrial) gene essentiality is context-dependent is
a conclusion borne out by other gene deletion studies under
different conditions, such as metabolic stress or drug
treatments33. We confirmed the results of our screening data by
silencing SDHC, and found that the growth of U2OS, MCF7, and
HeLa cells was improved under hypoxia. However, this effect was
not observed in HCT116 cells, which have a basal OCR twice that
of U2OS cells3, and whose growth we found was most impaired
by hypoxia (Supplementary Fig. 6b). Thus, the improvement in
fitness in hypoxia from the loss of SDHC and other OXPHOS
genes may be dependent on the degree to which tumour cell
proliferation is coupled to mitochondrial function. Several other
OXPHOS regulating genes were also significantly enriched in cells
from our screen in hypoxia compared to normoxia, including CI
subunits, and it was recently shown that single-gene deletions of
CI subunits improve the growth of HEK293T cells in hypoxia
compared to normoxia15. Notably, these findings also align with
observations that U2OS cells were consistently less sensitive to
low doses of the CI inhibitor rotenone in hypoxia compared to
normoxia (Supplementary Fig. 8). Indeed, we confirmed that a
reduction in certain OXPHOS proteins occurs in response to
chronic hypoxia, a response that has previously been reported to
maintain energetic and biosynthetic homoeostasis when mito-
chondrial activity is impaired34. While our study corroborates the
recent observation that loss of OXPHOS genes improves cell
fitness in hypoxia15, we found little gene to gene agreement with
respect to OXPHOS genes with the previous CRISPR/Cas9
hypoxia study15. However, while this may potentially signify
some gene specificity between cell lines used in different CRISPR
screens, it is important to consider that in general, gene by gene
differences between screens is a characteristic of large scale
screens of this kind due to the variability of gene rank and sig-
nificance between individual experiments. Thus here, we per-
formed three independent biological repeat screens of all
metabolic conditions (Supplementary Fig. 1a, Supplementary
Data 2–4), and our subsequent analysis was performed only on
those significantly depleted or enriched genes for each condition
that we identified on all three independent biological repeat
screens. Together with the use of a second generation vector
backbone as outlined here, and importantly for statistical con-
siderations, having at least five gRNA per gene in the CRISPR
library35 increases the statistical power of each experiment.
Interestingly, compared to normoxia, we identified that loss of
several genes involved in mRNA processing and translation, as
well as cytoskeleton regulation, improved the fitness of cells in
both hypoxia and galactose. Protein translation is an energetically
demanding process, and the downregulation of global translation
in hypoxia has been well characterised and linked to changes in
intracellular ADP/ATP ratios31,32. Cytoskeleton rearrangement is
a similarly energetically demanding process: for example, actin
polymerisation requires the hydrolysis of a molecule of ATP for
every addition of an actin monomer30. Thus, the improvement in
tumour cell viability through the loss of actin polymerisation
genes, and other cytoskeleton arrangement genes, may also be
due to the benefit this provides to bioenergetic homoeostasis. It
will be interesting to investigate whether changes in ATP avail-
ability in hypoxia (or in the presence of galactose) stimulate
signalling pathways that regulate cytoskeleton arrangement pro-
cesses in a similar manner to protein translation.
Our study did not find that peroxisome-related genes were
essential for the survival of U2OS cells in hypoxia, which was
described in a genome-wide CRISPR/Cas9 hypoxia screen using
K562 cells15. However, this peroxisome observation from the
CRISPR screen could only be verified in one cell line of four
tested, and could not be verified or recapitulated in the K562 cells
used for the screen15. This highlights that reproducibility and cell
to cell variability is an important consideration when interpreting
the results of genome-wide CRISPR screens of this type. Impor-
tantly, here, we sought to address this by comparing our results
with the pan-cancer gene essentiality data provided by the Broad
Institute’s Achilles project. Although this comparison has limited
applicability due to differences in methodology, conditions and
analysis pipelines, we were able to show from our over-
representation analyses that there was direct corroboration in our
depleted gene list, and the common essential genes identified by
the Achilles Project (compare Supplementary Fig. 2g, h). Never-
theless, we cannot exclude the possibility that some of the results
presented here are specific for U2OS cells. Indeed, while we found
that cytoskeletal gene depletion was beneficial for U2OS cell
growth in both hypoxia and galactose, this was not the case in
K562 cells used in previous galactose and hypoxia screens
described by the Mootha group14,15. This may represent a dif-
ference in cytoskeleton gene essentiality between adherent
(U2OS) and non-adherent (K562) cells.
Together, our study, to the best of our knowledge, provides
novel observations regarding the contextual nature of mito-
chondrial and non-mitochondrial gene essentiality in tumour
cells and also corroborates previous observations in other cell
types. In addition, different genes and pathways have been
identified that warrant further investigation for their utility as
therapeutic targets for both normoxic and hypoxic tumour cells.
Our study also cautions that the development of therapeutic
Fig. 4 Galactose sensitises cells to loss of mitochondrial genes and promotes loss of genes involved in energy-consuming processes. a Schematic
diagram shows which datasets were compared in our analysis (normoxia-galactose vs. normoxia-glucose). Sequencing reads from triplicate incubations
were analysed by the MAGeCK analysis platform, and relative sgRNA abundances were calculated between experimental conditions. b Pie charts show
number of mitochondrial genes among genes with significantly depleted or enriched sgRNAs from cells in normoxia-galactose compared to normoxia-
glucose. c Panel shows all mitochondrial genes with significantly depleted sgRNAs from (b). Genes significantly depleted in normoxia-glucose (plasmid vs.
library) are highlighted in brown. d Chart shows relative growth of U2OS cells incubated in 25mM normoxia-glucose or normoxia-galactose, and left
untreated (NT) or treated with 31.25 nM rotenone for 72 h. n= 3; mean ± S.D.; ***p < 0.001. e Chart shows overrepresentation analysis of all genes with
significantly enriched sgRNAs from (a). f Schematic diagram shows node of selected interacting genes with significantly enriched sgRNAs from (a)
involved in mRNA processing. g Chart shows all genes with significantly enriched gRNAs (robust rank aggregation (RRA) score, positive) from (a). Hexose
metabolism genes highlighted in blue.
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agents that target certain cellular processes, such as mitochondrial
metabolism or translation, must take into consideration that their
efficacy will depend on microenvironmentally induced adapta-
tions in tumour cells, such as those mediated by hypoxia.
Materials and methods
Cell culture. Human U2OS osteosarcoma, MCF7 breast carcinoma, HeLa cervi-
cal cancer, and HCT116 colon carcinoma cell lines were all obtained from
American Tissue Culture Collection (ATCC). All cell lines were maintained in
Dulbecco’s modified eagle medium (‘standard’ DMEM, #41965062, ThermoFisher
Scientific) containing glucose (4.5 g/L), and supplemented with 10% foetal calf
serum (FCS, SeraLabs), penicillin (100 IU/mL), streptomycin (100 μg/mL) and
glutamine (6 mM), all purchased from ThermoFisher Scientific. Cell lines used
were authenticated, and routinely confirmed to be negative for any mycoplasma
contamination. Hypoxia was achieved by incubating cells in 1% O2, 5% CO2 and
94% N2 in a Don Whitley H35 workstation, without agitation.
Generation of U2OS-Cas9 expressing cells. Human U2OS osteosarcoma cells
(U2OS-HRE-Luc cells24) were transduced with lentivirus prepared from the
pKLV2-EF1a-Cas9Bsd-W plasmid in the presence of polybrene (8 µg/mL)19. Fol-
lowing transduction, U2OS-Cas9 expressing cells were selected with blasticidin (20
µg/mL), and Cas9 expression and activity were confirmed. Briefly, to assess the
ability of the U2OS-Cas9 expressing cells to efficiently silence full-length gene
expression, cells were transduced with a lentivirus produced from the Cas9 reporter
vector, pKLV2-U6gRNA5(gGFP)-PGKBFP2AGFP-W which was a gift from
Kosuke Yusa (Addgene plasmid#67980; http://n2t.net/addgene:67980; RRID:
Addgene_67980)36. This vector contains BFP and GFP expressing cassettes, as well
as an sgRNA targeting GFP—efficient Cas9 activity would therefore be expected to
result in silencing of GFP signal. The ratio of BFP-only and GFP-BFP-double-
positive cells was analysed on a BD LSRFortessa instrument (BD Biosciences),
3 days post lentiviral transduction. The data were subsequently analysed using
FlowJo (BD Biosciences). Efficiently transduced U2OS-Cas9 cells showed high BFP
expression but the loss of GFP signal, indicating that the majority of the U2OS-
Cas9 cells expressed active Cas9.
Genome-wide CRISPR/Cas9 screen
Viral infection. The U2OS-Cas9 cells were lentivirally transduced with a genome-
wide CRISPR library of 90,709 sgRNAs targeting 18,009 human genes, at coverage of
at least five sgRNAs per gene36. In total, 3 × 107 cells were infected with lentiviral-
containing supernatant at an MOI of 0.3, allowing one sgRNA integration per cell and
therefore aiming to provide coverage of >100 cells expressing each sgRNA. The
lentiviral transduction of the U2OS-Cas9 cells with the CRISPR library was performed
independently three times, for three independent repeat screens. Each independent
repeat screen assessed three conditions in parallel, normoxia-glucose, hypoxia-glucose
and normoxia-galactose (Supplementary Fig 1a).
Puromycin selection and passaging. Two days after CRISPR library transduction,
cells were exposed to puromycin (2 µg/mL) for at least 10 days, then the U2OS-
Cas9 library cells were analysed on a BD LSRFortessa instrument (BD Biosciences)
to confirm >90% BFP positivity. The U2OS-Cas9 library cells were then selected
with puromycin for a further 4–5 days during expansion, and at least 20 × 106 cells
were carried forward after each passage to maintain the integrity of the CRISPR
library. Cells were cultured in Nunc® T175 triple flasks, and cell passaging was
carried out by washing with 22 mL of phosphate-buffered saline (PBS, Thermo-
Fisher #10010056), dissociated with 12 mL of 0.5% trypsin–EDTA (ThermoFisher
#25300096), and resuspended in 18 mL of media (DMEM, ThermoFisher
#41965062), per flask.
Setup of experimental conditions. After two weeks of puromycin selection and
expansion, the U2OS-Cas9 library cells were pooled, counted and at least 210 × 106
cells were plated into triple flasks (15 × 106 cells per triple flask) in ‘standard’
DMEM, then incubated at 37 °C/5% CO2/normoxia for 24 h. After 24 h, the
‘standard’ glucose-containing media was replaced with glucose-free galactose-
containing media (DMEM, #A14430, ThermoFisher Scientific, supplemented with
4.5 g/L D-(+)-galactose, 4 mM L-glutamine, 1 mM sodium pyruvate, and 10% FCS),
in a subset of flasks, to pre-condition the cells. To begin the screen, for each
experimental condition (described below), 21 × 106 U2OS-Cas9 library cells were
transferred to 7 separate triple flasks (3 × 106 cells per triple flask) and left to adhere
overnight under normal culturing conditions (37 °C/5% CO2/normoxia). The fol-
lowing day, the medium was replaced with fresh medium for each condition, and
cells were placed in the desired atmospheric conditions (normoxia or hypoxia (1%
O2)). Cells were grown for 5 days under the following experimental conditions: (1)
cells grown in ‘standard’ glucose-containing medium in normoxia (normoxia-
glucose), (2) cells grown in ‘standard’ glucose-containing medium in hypoxia at 1%
O2 (hypoxia-glucose), and (3) cells grown in glucose-free galactose-containing
medium in normoxia (normoxia-galactose). No passaging of cells was carried out
for the duration of the screen. Three independent repeat screens were performed,
each of which assessed three conditions in parallel, normoxia-glucose, hypoxia-
glucose, and normoxia-galactose (Supplementary Fig 1a).
Cell harvesting. After 5 days of culture under each experimental condition, U2OS-
Cas9 library cells from each condition were independently pooled, counted, pel-
leted, resuspended in 200 µL of PBS, and stored at −20 °C until further analysis.
Cell counts confirmed that at least 20 × 106 cells harvested from each condition
were taken forward for sequencing (Supplementary Fig. 1b).
Illumina sequencing of sgRNAs and statistical analysis. Genomic DNA
extraction and Illumina sequencing of sgRNAs were conducted as follows37. In brief,
72 μg of total extracted DNA was used to set up 36 polymerase chain reactions (PCR,
2 μg each) using 10 μM concentrations of forward and reverse primers (below) fol-
lowing which PCR products were purified using spin columns before a second PCR
reaction was carried out to incorporate indexing primers for each sample. DNA was





Enrichment and depletion of guides and genes were analysed using Robust
Ranked Aggregation in the MAGeCK statistical package (ver 0.5.6) by comparing
read counts from the Treatment samples with those from the Control samples and
using the ‘--min-number-goodsgrna min_number’ function to filter genes that
have less than 2 ‘good sgRNAs’, or sgRNAs that fall below the -p threshold (https://
sourceforge.net/projects/mageck/)25. As an initial quality control assessment, we
compared the Control samples to the Plasmid library for essential depleted genes.
We confirmed that the majority of depleted genes were those expressed at higher
levels, with almost no depletion for non-expressed genes. Additionally, gene set
enrichment analysis of genes based on their depletion scores confirmed that
essential biological processes for cell survival were the most significantly depleted
in each condition. These included genes from spliceosome, ribosome, DNA
replication and RNA polymerase families.
Antibodies. Antibodies used were as follows, with dilutions in parentheses: rabbit
polyclonal NDUFB10 (ab196019, 1:2000) from Abcam; rabbit polyclonal SDHA
(11998, 1:1000) from Cell Signaling Technology; rabbit polyclonal UQCRC2
(ab14745, 1:1000) from Abcam; rabbit polyclonal COXIV (4850, 1:10,000) from
Cell Signaling Technology; rabbit polyclonal BNIP3 (HPA003015, 1:2000) from
Cambridge Biosciences; rabbit polyclonal SDHC (PA5-79966, 1:1000) from Invi-
trogen; mouse monoclonal β-Actin (ab6276, 1:10,000) antibody from Abcam;
donkey anti-rabbit (NA934, 1:1000) and anti-mouse (NA931, 1:1000) horseradish
peroxidase (HRP)-linked secondary antibodies from VWR. Western blot signal
intensity was measured per lane using ImageJ (NIH) analysis software. Sample
protein band intensities were normalised to the load control protein β-Actin.
Relative band intensities were calculated relative to the internal control sample.
Respirometry. OCR was determined using a Seahorse XF96 Analyser (Seahorse
Bioscience). Respiratory profiles were generated by serial treatment with optimised
concentrations of oligomycin (1 µg/mL), p-[trifluoromethoxy]-phenyl-hydrazone
(FCCP, 500 nM), and rotenone (500 nM). Cell number normalisation was carried
out post-respirometry using sulforhodamine B (SRB) staining of TCA fixed cells in
the assay plate.
Quantitative PCR (QPCR) analysis. For gene expression analysis and mito-
chondrial copy number methodology using QPCR, see Supplementary Methods
and Supplementary Table 2.
siRNA transfection, compound treatment and SRB cell growth assays. Cells
were plated in appropriate tissue culture vessels and allowed to adhere overnight
prior to siRNA transfection or compound treatment.
siRNA transfection. Transfection complexes were made by combining 50 nM siRNA
(for siRNA sequences see Supplementary Table 3) with HiPerfect (QIAGEN) trans-
fection reagent in 100 μL serum-free DMEM. Complexes were then diluted in suffi-
cient DMEM containing either 25mM glucose or galactose (both with 10% foetal calf
serum (FCS, SeraLabs), penicillin (100 IU/mL), streptomycin (100 μg/mL) and glu-
tamine (6 mM)) for all samples. Media in wells removed then replaced with trans-
fection complex-containing media for 72 h. The transfection procedure was
then repeated, and cells were incubated for a further 48 h (5 days total).
Compound treatment. Standard growth media was replaced with compound free
DMEM containing either 25 mM glucose or galactose, or containing 31.25 nM
rotenone. Cells were then incubated in normoxia or hypoxia (1% O2) for 72 h.
SRB assay. At the end of incubation, media was removed, and cells were fixed with
10% (w/v) trichloroacetic acid (TCA) for 30 min. TCA was washed with water,
wells were allowed to air dry, and then an excess of 0.4% (w/v) SRB in 1% acetic
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acid was used to stain fixed cells for >10 min. Excess SRB was washed off with
1% (v/v) acetic acid solution. Bound SRB was resuspended in a suitable volume of
10 mM Tris, and absorbance of the solution measured at 570 nm.
Overrepresentation analysis. Common essential gene lists were accessed from the
Broad Institute Cancer Dependency Map data portal (https://depmap.org/portal/
download/)17,18. 19Q3 data release used throughout, covering 625 cell lines. Over-
representation analyses were carried out at the Broad Institute analysis portal (http://
software.broadinstitute.org/gsea/msigdb/annotate.jsp). FDR q-value set at 0.05.
Protein–protein association network analysis. Protein–protein association net-
works were generated using the stringApp v 1.5.1 in Cytoscape v 3.8.038. Proteins
in the networks were grouped based on their STRING interactions using Markov
clustering in the clusterMaker2 app (v 1.3.1)39, with additional manual curation.
Clusters were functionally characterised using the stringApp to perform functional
enrichment analysis, with the corresponding non-clustered network set as the
background.
Statistical analysis and reproducibility. A number of replicates (n), error bars
and p values are described in each figure legend. All statistical analysis of data
carried out in Microsoft Excel, apart from analysis of sgRNA sequencing data
which was carried out in MAGeCK (version 0.5.5). For growth assays and QPCR,
conditions were compared by two-tailed unpaired t tests. For comparison of
sgRNA abundances, all genes were ranked for enrichment and depletion separately
by the α-RRA method in MAGeCK25. Multiple comparison correction was applied
using the Benjamini–Hochberg method, following exclusion of genes with fewer
than 2 ‘good’ targeting sgRNAs (p < 0.1), and an FDR threshold of 0.3 (30%) was
applied.
Reporting summary. Further information on research design is available in the Nature
Research Reporting Summary linked to this article.
Data availability
Genes identified from the functional annotation of all MitoCarta 2.0 genes represented in
Achilles Cancer Dependency essentiality dataset described in Fig. 1, are included in
Supplementary Data 1. For our CRISPR/Cas9 screens, the raw read counts, the ranked
gene lists (enriched and depleted genes), and MAGeCK analysis data (FDR-corrected p
value) for each condition and repeat screen (Supplementary Fig. 1a) are included in the
Supplementary Data 2–4. The FDR-corrected significance values for all genes with
significantly depleted sgRNAs at different FDR thresholds (<10%, <20%, <30%, >30%)
for each condition and repeat screen are included in Supplementary Fig. 2a–c. Raw data
for charts (Fig. 3b, d–f, Fig. 4d and Supplementary Fig. 4b) are included in
Supplementary Data 5. Raw western analysis data for Fig. 2e and Fig. 3c are included in
Supplementary Figs. 9 and 10. For any further information, or reasonable requests, please
contact the corresponding author.
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